29 year old Linzi Atkinson was diagnosed with kidney cancer in 2017. She has had her kidney removed and is living a healthy life following open surgery.
New data from a Phase 1 clinical trial shows that ARMO BioSciences‘ immunotherapy AM0010 (pegilodecakin), alone or in combination with immune checkpoint inhibitors, shows high and durable clinical responses in patients with advanced renal cell carcinoma (RCC).
Kidney Cancer UK and Kidney Cancer Scotland are pleased to announce that Monday 5th to the Friday 9th February will be Kidney Cancer Awareness Week 2018 across the United Kingdom, #KCAW2018, culminating in 'Green Friday' on 9th February.
Hollyann Prince was just 23 when her health took a turn which led to a misdiagnosis and subsequently a delayed diagnosis of kidney cancer
Linzi Atkinson, 29, was diagnosed with kidney cancer in May 2017 and underwent open surgery to have her kidney removed. During her recover she found herself wanting to eat healthy food to help her body recover.
A vaccine against metastatic renal cell carcinoma appears to have some activity in patients who receive engineered autologous dendritic cell infusions, researchers reported here at the International Kidney Cancer Symposium.
Updated results from a phase 3 study demonstrated that patients with advanced renal cell carcinoma (RCC) treated with nivolumab had significantly superior rates of 3-year overall survival (OS) compared with everolimus,
A combination of Bristol-Myers Squibb’s Opdivo (nivolumab)and Yervoy (ipilimumab) has failed to significantly improve progression-free survival (PFS) compared to Pfizer’s Sutent in patients... Read More